Achievement of Goal Resting Heart Rate on B-blockers in Patients With Stable Angina and Hypertension (Athena)

AstraZeneca

Status: Completed

Conditions: Hypertension; Stable Angina

Study type: Observational

Funder types: Industry

Identifiers

NCT01321242

NIS-CRU-ATC-2011/1

Details and patient eligibility

About

This is a multicenter survey of Russian data on target heart rate achievement in patients with stable angina and arterial hypertension who are currently treated with beta-blockers for at least 2 months and with no dose change for a minimum of 4 weeks

Enrollment: 400 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Stable angina I-III class by the Canadian Cardiovascular Society Classification and concomitant primary hypertension
• Subject is on beta-blockers treatment for at least 2 months prior to inclusion into survey, with no dose change for a minimum of 4 weeks

Exclusion criteria

• Use of phenylalkylamine and benzothiazepine calcium channel blockers
• Hemodynamic significant mitral and aortic valve disease
• Acute myocardial infarction and unstable angina within 3 months before enrolment

Trial design

400 participants in 2 patient groups

achieving resting HR goals

Description:

Patient population will be comprised of typical for cardiological practice sample of patients with Coronary Heart Disease and arterial hypertension administered beta-blockers, subjects achieving resting HR goals, according to ACC/AHA/ACP-ASIM Guidelines

non-achieving HR goals

Description:

Patient population will be comprised of typical for cardiological practice sample of patients with Coronary Heart Disease and arterial hypertension administered beta-blockers, subjects non-achieving HR goals, according to ACC/AHA/ACP-ASIM Guidelines